Researchers in the US have found that changes in the blood vessels of the eye are associated with a greater decline in people's memory and language skills over a 20-year period. Their findings are published today in the scientific ...
Mar 1, 2018
0
1
How many times have you been told that something great will happen as long as you believe it is possible? From pop psychology books to self-improvement seminars and blogs, there's a lot of hype surrounding the advantages ...
Feb 26, 2018
0
57
(HealthDay)—New Year's resolutions to curb drinking are likely made with the best intentions. But wishful thinking often isn't enough, a new survey suggests.
Jan 30, 2018
0
2
Scientists in the US have found that electrically stimulating regions of the brain in three people with Alzheimer's disease was safe and appeared to show an effect on thinking skills and day-to-day tasks in two of the volunteers. ...
Jan 30, 2018
0
11
(HealthDay)—Scientists may have discovered what makes a creative mind tick: stronger connections among brain regions that usually work in opposition to each other.
Jan 17, 2018
1
12
Peripheral intravenous cannula (PIVC) insertion in the emergency department can be reduced using a multimodal approach designed to support critical thinking and promote clinically appropriate peripheral intravenous cannula ...
Dec 27, 2017
0
4
In a small study using data from daily electronic patient diaries, Johns Hopkins researchers say they have found a link between negative emotions, such as sadness and anxiety, and higher opioid use in people with sickle cell ...
Nov 27, 2017
0
1
Researchers at the Center for BrainHealth at UT Dallas have demonstrated in a pilot study that cognitive training improves innovative thinking, along with corresponding positive brain changes, in healthy adults over the age ...
Nov 14, 2017
0
4
The moon landing and global warming are hoaxes. The U.S. government had advance knowledge of the 9/11 attacks. A UFO crashed in Roswell, New Mexico.
Nov 14, 2017
1
161
The pharmaceutical company Biogen has today announced the results of an extended phase 1b clinical trial of the potential Alzheimer's disease drug, aducanumab. Results from the extended early stage trial, were announced today ...
Nov 3, 2017
0
22
